Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure

Journal of Association of Physicians of India

Volumn 50, Issue 5, 2002, Pages 641-646

  Zargar, A H ^a   Masoodi, S R ^a   Laway, B A ^a   Wani, A I ^a   Bashir, M I ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; INSULIN;

ARTICLE; BLOOD; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TREATMENT FAILURE;

EID: 0036561346     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus : results of a 25 year follow-up study. Lancet 1992;340:925-9.
2. Gerich JE. Oral hypoglycemic agents. N Engl J 'Med 1989;321:1231-45.
3. Groop LC. Sulfonylureas in NIDDM. Diabetes Care 1992;15:737-54.
4. Hermann LS, Schersten B, Bitzen PO, Kjellstrom T, Lindgarde F, Melander A. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations, A double-blind controlled study. Diabetes Care 1994;17:1100-9.
5. Peters AL, Davidson MB. Insulin plus a sulfonylurea agent for treating type 2 diabetes. Ann Intern Med 1991;115:45-53.
6. Williams B, Lehman P. In : European fructosamine workshop Vienna 1989. Henricks HR, ed. Wien Klin Wschr 1990;102,3(Supple):9-12.
7. Kumar S, Mukherjee S. Drug therapy in type 2 diabetes mellitus. Indian J Endocrinol Metab 1997;1:32-7.
8. Stenman S, Groop PH, Saloranta C, Totterman KJ, Fyhrquist F, Groop L. Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents. Diabetologia 1988;31:206-13.
9. Pugh JA, Ramirez G, Wagner ML, Tuley M, Sawyer J, Friedberg SJ. Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis. Diabetes Care 1992;5:953-9.
10. Mohan V, Snehalatha C, Ramachandran A, Viswanathan M. Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs. J Assoc Phys India 1990;38:537-41.
11. Kyllastinen M, Groop L. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients. Ann Clin Res 1985;17:100-9.
12. Geuth S. Management of the adult onset diabetic with sulfonylurea drug failure. Clin Endocrinol Metab North Am 1992;21:351-70.
13. Gutniak M, Karlander SG, Efendic S. Glyburide decreases insulin requirement, increases B-cell response to mixed meal, and does not affect insulin sensitivity; effects of short and long-term combined treatment in secondary failure to sulfonylurea. Diabetes Care 1987;10:545-8.
14. Krempf M, Godeau T, Ranganathan S, Blanchard P, Ritz P, Charbonnel B. Effects of a combination of bedtime intermediate-acting insulin and glibenelamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents. Eur J Clin Pharmacol 1992;42:281-6.
15. Soneru IL, Agrawal I, Murphy JC, Lawrence AM, Abraira C. Comparison of morning or bedtime insulin with or without glyburide in secondary sulfonylurea failure. Diabetes Care 1993;16:896-901.
16. Riddle MC. New tactics for type 2 diabetes : regimens based on intermediate acting insulin taken at bed time. Lancet 1985;1:192-5.
17. Olefsky JM. Pathogenesis of insulin resistance and hyperglycaemia in non-insulin dependent diabetes mellitus. Am J Med 1985;79:1-7.
18. Defronzo RA, Fernannini E, Koivisto V. New concepts in the pathogenesis and treatment of non-insulin dependent diabetes mellitus. Am J Med 1983;74:52-81.
19. Del Prato S. Rationale for the association of sulfonylurea and insulin. Am J Med 1991;90:77-82.
20. Clauson P, Karlander S, Steen L, Efendic S. Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulfonylurea failure : A 1-year follow up. Diabet Med 1996;13:471-7.